Official UK procurement notice
Provision of HLA Antibody Detection & Identification Services
Authority: Belfast Health & Social Care Trust (Central government)
What is being bought
Published requirement descriptionProcurement of HLA Antibody Detection & Identification Services
CPV: Medical equipments, pharmaceuticals and personal care products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 14 Nov 2023, 10:18 GMT
- Last source update
- 13 Dec 2023, 09:02 GMT
- Authority reference
DAC12041- FTS notice number
2023/S 000-036593- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04197fFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
No other reasonable alternative exists for this procurement that is critical for patient care and service delivery. This procurement is essential in supporting the long-term/optimum graft survival of renal transplant patients. A tender process that was delayed due to Covid19 commenced in September 2021, tender reference 3786726 and is currently at evaluation stage. This procurement is required in the interim period until this tender process has completed. A replacement in the short-term is not a reasonable alternative as it would require extensive and robust validation and verification work in line with laboratory accreditation standards - UKAS ISO15189 that would result in significant disruption and disproportionate technical difficulties that would significantly impact on patient safety and the Trusts ability to deliver services.
The absence of competition is not a result of the artificial narrowing of the parameters of the procurement. The wider market has been consulted as part of the tender that is in progress HLA Typing & Antibody Ref: 3786726. BHSCT will exit this procurement and transition to the new contract at the earliest opportunity.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| VH Bio Ltd | £275,000 †same award published again · counted once | — | Awarded |
| VH Bio Ltd | £275,000 † | — | Awarded |
Contracts
Provision of HLA Antibody Detection & Identification Services · VH Bio Ltd
- Signed
- 1 Dec 2023
- Value
- £275,000
- Status
- active
Provision of HLA Antibody Detection & Identification Services · VH Bio Ltd
- Signed
- 14 Nov 2023
- Value
- £275,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- VH BIO LTDAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.